Meningococcal ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
On This Page
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Meningococcal Vaccine Recommendations
- MMWR, September 25, 2020, Vol 69 #9
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
Print version pdf icon[44 pages] - See also:
ARCHIVED Historical Meningococcal Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, May 19, 2017, Vol 66 #19
Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
Print version pdf icon[5 pages] - MMWR, November 4, 2016, Vol 65 #43
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
Print version pdf icon[6 pages] - MMWR, October 23, 2015, Vol 64 #41
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
Print version pdf icon[24 pages] - MMWR, June 12, 2015, Vol 64 #22
Use of Serogroup B Meningococcal (MenB) Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
Print version pdf icon[16 pages] - MMWR, June 20, 2014, Vol 63 #24
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk, 2013
Print version pdf icon[16 pages] - MMWR, March 22, 2013, Vol 62, #RR02
Prevention and Control of Meningococcal Disease
Print version pdf icon[32 pages] - MMWR, January 25, 2013, Vol 62, #3
Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
Print version pdf icon[32 pages] - MMWR, October 14, 2011, Vol 60, #40
Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Print version pdf icon[2.03MB, 36 pages] - MMWR, August 5, 2011, Vol 60, #30
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — ACIP, 2011
Print version pdf icon[1.12MB, 36 pages] - MMWR, January 28, 2011, Vol 60, #03
Updated Recommendations for Use of Meningococcal Conjugate Vaccines — ACIP, 2010
Print version pdf icon[28 pages] - MMWR, March 12, 2010, Vol 59, #09
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use — ACIP, 2010
Print version pdf icon[20 pages] - MMWR, September 25, 2009, Vol 58, #37
Updated Recommendation from the ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Print version pdf icon[1.49MB, 32 pages] - MMWR, May 2, 2008, Vol 57, #17
Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Print version pdf icon[28 pages] - MMWR, December 7, 2007, Vol 56, #48
Notice to Readers: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease
Print version pdf icon[24 pages] - MMWR, August 10, 2007, Vol 56, #31
Notice to Readers: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
Print version pdf icon[28 pages] - MMWR, November 3, 2006, Vol 55, #43
Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years
Print version pdf icon[23 pages] - MMWR, September 22, 2006, Vol 55, #37
Inadvertent Misadministration of Meningococcal Conjugate Vaccine — United States, June-August 2005
Print version pdf icon[24 pages] - MMWR, May 26, 2006, Vol 55, #20
Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years
Print version pdf icon[32 pages] - MMWR, May 27, 2005, Vol 54, #RR-07
Prevention and Control of Meningococcal Disease
Print version pdf icon[28 pages] - MMWR, Feb 14, 1997, Vol 46, #RR-5
Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP
(PDF not available)
Page last reviewed: October 22, 2015
Content source: National Center for Immunization and Respiratory Diseases